BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3048326)

  • 1. Differentiation, cancer, and anticancer activity.
    Tzen CY; Estervig DN; Minoo P; Filipak M; Maercklein PB; Hoerl BJ; Scott RE
    Biochem Cell Biol; 1988 Jun; 66(6):478-89. PubMed ID: 3048326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation, dedifferentiation, and transdifferentiation of BALB/c 3T3 T mesenchymal stem cells: potential significance in metaplasia and neoplasia.
    Sparks RL; Seibel-Ross EI; Wier ML; Scott RE
    Cancer Res; 1986 Oct; 46(10):5312-9. PubMed ID: 3756880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonterminal differentiation represses the neoplastic phenotype in spontaneously and simian virus 40-transformed cells.
    Scott RE; Estervig DN; Tzen CY; Minoo P; Maercklein PB; Hoerl BJ
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1652-6. PubMed ID: 2537979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated control of proliferation and differentiation of mesenchymal stem cells.
    Filipak M; Estervig DN; Tzen CY; Minoo P; Hoerl BJ; Maercklein PB; Zschunke MA; Edens M; Scott RE
    Environ Health Perspect; 1989 Mar; 80():117-25. PubMed ID: 2647473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An initiator of carcinogenesis selectively and stably inhibits stem cell differentiation: a concept that initiation of carcinogenesis involves multiple phases.
    Scott RE; Maercklein PB
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2995-9. PubMed ID: 3857629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective control of terminal differentiation and its role in carcinogenesis in the 3T3 T proadipocyte stem cell line.
    Wier ML; Scott RE
    Cancer Res; 1985 Jul; 45(7):3339-46. PubMed ID: 4005857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of anticancer activity induced by cellular differentiation.
    Maercklein PB; Estervig DN; Scott RE
    Lab Invest; 1990 Feb; 62(2):196-201. PubMed ID: 2304332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of tumorigenicity by the cell-cycle-dependent control of cellular differentiation and proliferation.
    Wille JJ; Scott RE
    Int J Cancer; 1986 Jun; 37(6):875-81. PubMed ID: 3710616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of differentiation control in transformed 3T3 T proadipocytes.
    Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
    Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to neoplastic transformation induced by nonterminal differentiation.
    Estervig DN; Maercklein PB; Scott RE
    Cancer Res; 1989 Feb; 49(4):1008-13. PubMed ID: 2912546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation, differentiation/gene therapy and cancer.
    Scott RE
    Pharmacol Ther; 1997; 73(1):51-65. PubMed ID: 9014206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor inhibits the terminal event in mesenchymal stem cell differentiation.
    Filipak M; Sparks RL; Tzen CY; Scott RE
    J Cell Physiol; 1988 Nov; 137(2):367-73. PubMed ID: 3192620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation can convey resistance to transformation by activated ras oncogene.
    Tzen CY; Maercklein PB; Scott RE
    Anticancer Res; 1990; 10(5A):1329-34. PubMed ID: 2241110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of distinct steps in the adipocyte differentiation pathway in 3T3 T mesenchymal stem cells by dimethyl sulphoxide (DMSO).
    Wang H; Scott RE
    Cell Prolif; 1993 Jan; 26(1):55-66. PubMed ID: 8439589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of differentiation, proliferation and cancer suppressor activity.
    Scott RE; Tzen CY; Witte MM; Blatti S; Wang H
    Int J Dev Biol; 1993 Mar; 37(1):67-74. PubMed ID: 7685184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coupling of proadipocyte growth arrest and differentiation. II. A cell cycle model for the physiological control of cell proliferation.
    Scott RE; Hoerl BJ; Wille JJ; Florine DL; Krawisz BR; Yun K
    J Cell Biol; 1982 Aug; 94(2):400-5. PubMed ID: 6809770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multistep process of squamous differentiation in tracheobronchial epithelial cells in vitro: analogy with epidermal differentiation.
    Jetten AM
    Environ Health Perspect; 1989 Mar; 80():149-60. PubMed ID: 2647475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors.
    Gabrilovich DI; Cheng P; Fan Y; Yu B; Nikitina E; Sirotkin A; Shurin M; Oyama T; Adachi Y; Nadaf S; Carbone DP; Skoultchi AI
    J Leukoc Biol; 2002 Aug; 72(2):285-96. PubMed ID: 12149419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the terminal event in cellular differentiation: biological mechanisms of the loss of proliferative potential.
    Wier ML; Scott RE
    J Cell Biol; 1986 May; 102(5):1955-64. PubMed ID: 2422182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth and differentiation signals as determinants of cancer cell proliferation.
    Bloch A
    Adv Enzyme Regul; 1989; 28():359-74. PubMed ID: 2696345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.